Cargando…
Augmented renal clearance
Adding to the complexity of caring for critically ill patients is the fact that many of them have a creatinine clearance that exceeds 130 mL/min/1.73 m(2). This phenomenon, termed augmented renal clearance (ARC), has only recently been widely recognized and its pathogenesis remains incompletely unde...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989233/ https://www.ncbi.nlm.nih.gov/pubmed/32055559 http://dx.doi.org/10.12793/tcp.2018.26.3.111 |
_version_ | 1783492363914575872 |
---|---|
author | Atkinson, Arthur J. |
author_facet | Atkinson, Arthur J. |
author_sort | Atkinson, Arthur J. |
collection | PubMed |
description | Adding to the complexity of caring for critically ill patients is the fact that many of them have a creatinine clearance that exceeds 130 mL/min/1.73 m(2). This phenomenon, termed augmented renal clearance (ARC), has only recently been widely recognized and its pathogenesis remains incompletely understood. However, ARC has been shown to result in increased dose requirements for drugs that are primarily eliminated by renal excretion, including many antimicrobial agents and enoxaparin. Recognition of ARC is hampered by the fact that the standard creatinine-based equations used to estimate renal function are not accurate in this clinical setting and the diagnosis is best established using both serum and urine creatinine measurements to calculate clearance. So a high index of clinical suspicion and awareness is usually required before this step is taken to confirm the diagnosis of ARC. |
format | Online Article Text |
id | pubmed-6989233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Korean Society for Clinical Pharmacology and Therapeutics |
record_format | MEDLINE/PubMed |
spelling | pubmed-69892332020-02-13 Augmented renal clearance Atkinson, Arthur J. Transl Clin Pharmacol Tutorial Adding to the complexity of caring for critically ill patients is the fact that many of them have a creatinine clearance that exceeds 130 mL/min/1.73 m(2). This phenomenon, termed augmented renal clearance (ARC), has only recently been widely recognized and its pathogenesis remains incompletely understood. However, ARC has been shown to result in increased dose requirements for drugs that are primarily eliminated by renal excretion, including many antimicrobial agents and enoxaparin. Recognition of ARC is hampered by the fact that the standard creatinine-based equations used to estimate renal function are not accurate in this clinical setting and the diagnosis is best established using both serum and urine creatinine measurements to calculate clearance. So a high index of clinical suspicion and awareness is usually required before this step is taken to confirm the diagnosis of ARC. Korean Society for Clinical Pharmacology and Therapeutics 2018-09 2018-09-14 /pmc/articles/PMC6989233/ /pubmed/32055559 http://dx.doi.org/10.12793/tcp.2018.26.3.111 Text en Copyright © 2018 Translational and Clinical Pharmacology http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/). |
spellingShingle | Tutorial Atkinson, Arthur J. Augmented renal clearance |
title | Augmented renal clearance |
title_full | Augmented renal clearance |
title_fullStr | Augmented renal clearance |
title_full_unstemmed | Augmented renal clearance |
title_short | Augmented renal clearance |
title_sort | augmented renal clearance |
topic | Tutorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989233/ https://www.ncbi.nlm.nih.gov/pubmed/32055559 http://dx.doi.org/10.12793/tcp.2018.26.3.111 |
work_keys_str_mv | AT atkinsonarthurj augmentedrenalclearance |